15 March 2018

My name is Paola de Haas, I am Dutch and I am a PhD candidate in the department of Cell Biology in the theme Nanomedicine.

When you were a kid what did you want to be when you grew up? Can you tell us something about your child years. 

When I was a kid I wanted to be all kinds of different things when I grew up. When I was very little I wanted to become a mailman, because I thought that I would always know the way and never get lost. Later on it changed into a vet because I would really enjoy working with animals. Then at some point I changed the animals for humans and I wanted to become a medical doctor. This idea stuck with me until I started studying Medical Biology and I realized a career in research suited me much better.

What was your previous academic training, where did you study and why that study? 

I studied Medical Biology at the Radboud University. Biology was always my favourite subject, I was interested in the way things worked. Even though I also really enjoyed plant and animal related courses, my main interests were still related to the human body in health and disease.

The RIMLS motto is “Today’s molecules for tomorrow’s medicine”. What does this mean for you? 

The research I do is quite strongly related to patients and is aimed at trying to understand the molecular basis of their disease and symptoms. I am studying a subtype of the congenital disorders of glycosylation (CDG) in which patients have an impaired N-glycosylation. I think in this study molecules can not only help to gain knowledge about the disease but in addition looking at the patient phenotype can help us understand something about the role of molecules, N-glycans in my case.

Who is your great example as scientists? And please give a motivation why.

That is a difficult one! I think I would choose Jonas Salk, who developed the first successful vaccine against polio. He volunteered himself to take part in the clinical trial to test the vaccine. When the vaccine became available for everyone he did not patent it because he thought it belonged to the people. I think that shows real dedication and passion for an important goal in science, to improve healthcare.

Which research discovery that you have made has made you most proud? 

I haven’t made any big discoveries so far, so I will safe this question for later in my PhD.

Given unlimited finance what experiment would you perform?

In the disease I am studying not only the amount of money but also the availability of patient material is limiting. Therefore I would want to invest in optimizing protocols to differentiate patient derived induced pluripotent stem cells to the different cell types which play a role in CDG and in developing organoids and organ-on-a-chip models to study tissues that are hard to gain access to, such as brain and heart

What does your working area (desk, office) look like and what does it say about you (or your research)?

It varies a lot. When I am very busy, running from one experiment to another, it can get a bit messy. Then at some point the mess starts to annoy me and I will tidy everything up at once.

Nominate a colleague to be in the spotlight and what would you like to ask him or her?

I would like to nominate Marieke Willemse and I would like to ask her what her favourite cell type is to look at under the microscope.

What type of person are you, quick insights:

a) Mac or PC?                                : PC
b) Theater or cinema?                 : Cinema
c) Dine out or dine in?                 : Dine in
d) Ferrari or Fiat?                         : Fiat
e) Shopaholic or chocoholic?     : Chocoholic
f) Culture or Nature                     : Nature

Related news items

Identification of dozens of ovarian cancer genes

21 August 2018

In Cancer Research, a global consortium in which Leon Massuger and Bart Kiemeney participate describes the identification of dozens of low-penetrance genes at genomic loci that were previously associated with ovarian cancer.

read more

Thermogels to the rescue

20 August 2018

In a recent publication in Biomaterials, a multidisciplinary team from Radboudumc, Radboud University and the Association of Dutch Burn Centres present their first results with a recently developed thermogel for use in wound repair.

read more

Brain specific mutations may only explain sporadic Alzheimer's disease in very few cases

20 August 2018

Alexander Hoischen, theme Infectious diseases and global health, and colleagues studied brain- and blood-DNA of sporadic early-onset Alzheimer’s disease (AD) patients, for somatic mutations in the known AD genes.

read more

Poster prize Lars Damen at 10th European Elastin Meeting

17 August 2018

At the 10th European Elastin Meeting, Lars Damen, theme Reconstructive and regenerative medicine, received the early-stage researcher award for his poster entitled “Development of tools to study the sulfation pattern of heparan sulfate involved in elastic fiber biology”.

read more

Natural Killer cell therapy Hematology teams up with MWH4impact

25 July 2018

The Departments of Laboratory Medicine and Hematology entered into a partnership with the Social impact foundation MWH4impact on Natural Killer cell therapy.

read more

Prinses Beatrix Spierfonds grant for Rick Wansink and Frank Walboomers

23 July 2018

Rick Wansink, theme Nanomedicine, and Frank Walboomers, theme Reconstructive and regenerative medicine, have been awarded a 250.000 EUR grant of the Prinses Beatrix Spierfonds towards the study and elucidation of myotonic dystrophy, in a project entitled: Harmful RNA in myotonic dystrophy.

read more
  • Go to